Pricing
ANEUROTECH is developing its late stage Phase III drug ANT01 in Partial Responsive Depression (PRD). ANT01 is an once daily, orally-administered small molecule to attack Subjective Cognitive Decline and Potentiate Initial Antidepressant Therapies.
Headquarters
Employees
Links
Org chart
Teams
Offices
Positions (2)
Unverified
This company has no teams yet
This company has no offices yet